Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Why Is Novavax (NVAX) Stock Up 20% Today?
04:51pm, Wednesday, 05'th Jun 2024
Novavax (NASDAQ: NVAX ) is on a recovery trek after collapsing in late 2021. Recently, management said that its latest vaccine version addressing newer Covid-19 subvariants is more effective than olde
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
01:01pm, Tuesday, 04'th Jun 2024
An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in
Growth Stocks to Avoid Like the Plague: 3 Overpriced Picks Primed to Plummet
06:01am, Saturday, 01'st Jun 2024
Growth stocks can be millionaire-makers and the same ideas can be destroyers of wealth. The difference between wealth creation and erosion is the timing of exposure.
Novavax to Participate in 2024 Jefferies Global Healthcare Conference
09:25am, Thursday, 30'th May 2024
GAITHERSBURG, Md. , May 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
10:05am, Tuesday, 28'th May 2024
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
04:19pm, Friday, 24'th May 2024
Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant that was dominant earlier this
Why Vaccine Stocks Rallied This Week
08:15am, Friday, 24'th May 2024
H5N1 bird flu was detected this week in Michigan and Australia. It's the first detection in humans since March, when news of an outbreak in cattle emerged.
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
06:45am, Thursday, 23'rd May 2024
Novavax (NASDAQ: NVAX ) stock was among the laggards in the race for the vaccine against COVID-19. Unsurprisingly, NVAX stock plunged from highs of $320 in 2021 to recent lows of $3.5.
3 Biotech Stocks to Buy Now: May 2024
10:48am, Wednesday, 22'nd May 2024
While it tends to fly under the radar for many people, the biotech industry has seen a resurgence in investor interest over the last couple of years. While there could be several reasons for this, s
Better Buy: Inovio Pharmaceuticals vs. Novavax
09:45am, Wednesday, 22'nd May 2024
Novavax just signed a lucrative agreement with a biotech giant. Inovio Pharmaceuticals is inching closer to launching its leading candidate.
3 Things You Need to Know If You Buy Novavax Today
05:50am, Wednesday, 22'nd May 2024
Novavax stock surged after the company announced a partnership with pharma giant Sanofi. The biotech stock has spent the past few years in the doldrums after sales of its coronavirus vaccine disappoin
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
10:05am, Tuesday, 21'st May 2024
Novavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company. This withdrawal is in sync with the company?
The $10 Stock Jackpot: 3 Speculative Plays That Could Double Overnight
06:27am, Tuesday, 21'st May 2024
The price-action in some speculative stocks in the recent past is signaling the possible return of the meme stock euphoria. Stocks like Novavax (NASDAQ: NVAX ) doubled overnight, and the rally has eve
Roaring Kitty's Rally Cry: 3 Meme Stocks to Pounce On Now
01:37pm, Monday, 20'th May 2024
GameStop (NYSE: GME ) and AMC (NYSE: AMC ) meme stocks rose substantially last week, gaining over 70%. The return of ‘Roaring Kitty', prominent investor Keith Gill, has traders wondering which meme
Shah Capital ends campaign against Novavax board after Sanofi deal
07:40am, Monday, 20'th May 2024
Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's board, after the COVID-19 vaccine maker struck a licensing deal with Sanof
